Monday, February 28, 2011
A Little More on the Intellectual Property Issue...
After writing my last post about the bedside micro-NMR (µNMR) device that might speed cancer diagnosis, I remained curious about the lack of financial conflicts.
One of the lead authors on the paper, Cesar M. Castro, MD, an oncologist at Massachusetts General Hospital, was kind enough to provide more details. He said MGH holds the patent on the device and that the technology is not currently licensed to an outside group.
“As far as I know, there are no plans to pursue commercialization or strategic partnerships in the near future as we seek to further optimize the device,” Dr. Castro wrote in an email message. “Moreover, we have enough non-dilutive funding secured through scientific grants to allow us to continue the course.”
I’m glad to have the extra information, and I’ll be looking forward to seeing their next paper.